BOTOX
BOTOX is a pharmaceutical drug with 97 clinical trials. Currently 3 active trials ongoing. Historical success rate of 89.9%.
Success Metrics
Based on 71 completed trials
Phase Distribution
Phase Distribution
24
Early Stage
15
Mid Stage
44
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
84.5%
71 of 84 finished
15.5%
13 ended early
3
trials recruiting
97
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study to Evaluate Sequential Administration of Injections of AGN-151586 Followed by BOTOX in Adult Participants for Treatment of Glabellar Lines
A Study to Assess BOTOX Injections in Adult Participants for the Change of Masseter Muscle Prominence
A Study to Assess BOTOX Injections for the Change of Masseter Muscle Prominence in Adult Participants
A Study to Assess Adverse Events and Change of Masseter Muscle Prominence Using BOTOX Injections in Adult Participants
A Study to Evaluate Sequential Administration of AGN-151586 and OnabotulinumtoxinA (BOTOX) Injections in Adult Participants for Treatment of Glabellar Lines
Clinical Trials (97)
A Study to Evaluate Sequential Administration of Injections of AGN-151586 Followed by BOTOX in Adult Participants for Treatment of Glabellar Lines
A Study to Assess BOTOX Injections in Adult Participants for the Change of Masseter Muscle Prominence
A Study to Assess BOTOX Injections for the Change of Masseter Muscle Prominence in Adult Participants
A Study to Assess Adverse Events and Change of Masseter Muscle Prominence Using BOTOX Injections in Adult Participants
A Study to Evaluate Sequential Administration of AGN-151586 and OnabotulinumtoxinA (BOTOX) Injections in Adult Participants for Treatment of Glabellar Lines
A Phase 3 Clinical Study to Evaluate the Efficacy and Safety of Botulinum Toxin Type A for Injection (CU-20101)
Early Administration of Botox® in Neuropathic Pain Due to Thoracoscopy or Thoracotomy
A Clinical Study on Recombinant Botulinum Toxin Type A (YY001) for Injection in The Treatment of Upper Limb Spasticity in Adults
Study of BOTOX Injections to Assess Change in Disease Symptoms in Adult Participants With Upper Limb Essential Tremor
A Study to Assess the Effectiveness of BOTOX (Botulinum Toxin Type A) Injections for the Change of Masseter Muscle Prominence in Adult Participants
Study of BOTOX Injections in Prevention of Migraine in Adult Participants With Episodic Migraine
A Study to Evaluate Participant Satisfaction and Natural Outcomes Following Administration of BOTOX Cosmetic Injections in Adult Participants for Treatment of Upper Facial Lines
A Study to Assess the Adverse Events and Effectiveness of BOTOX Injections for the Treatment of Moderate to Severe Forehead Lines in Chinese Adult Participants
Study to Evaluate Subject Satisfaction With Facial Appearance and Impact of Combined Facial Treatment
Study of BOTOX Injections to Assess Change in Disease Activity and Adverse Events in Adult Female Participants With Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)
A Phase I/II, Randomized, Double-blind, Placebo, and Active Controlled Clinical Study to Evaluate the Safety, Tolerability, Immunogenicity, and Preliminary Efficacy of JHM03 in Subjects With Moderate to Severe Glabellar Lines
Treatment of Gastrocnemius Tightness and Subsequent Chronic Plantar Fasciitis with Botulinum Toxin a
Double-blind Comparative Randomized Multicenter
Female Sexual Dysfunction Assessment and Managment of Vaginismus
Botox for the Treatment of Recurrent Chronic Exertional Compartment Syndrome
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 97